We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$71.5B
AUM Growth
+$3.66B
(+5.4%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
1,538
New
294
Increased
526
Reduced
448
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$268M |
| 2 |
General Motors
GM
|
+$263M |
| 3 |
AstraZeneca
AZN
|
+$235M |
| 4 |
Vale
VALE
|
+$226M |
| 5 |
Oracle
ORCL
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$606M |
| 3 |
Canadian Natural Resources
CNQ
|
+$552M |
| 4 |
Bank of America
BAC
|
+$490M |
| 5 |
AbbVie
ABBV
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 20.13% |
| 3 | Consumer Discretionary | 15.62% |
| 4 | Financials | 9.5% |
| 5 | Energy | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZIMV
801
DELISTED
ZimVie
ZIMV
| $2.73M | ﹤0.01% |
+291,938
| New | +$2.55M |
|
802
UiPath
PATH
$8.14B
| $2.71M | ﹤0.01% |
+213,478
| New | +$2.64M |
|
803
Zumiez
ZUMZ
$322M
| $2.69M | ﹤0.01% |
123,788
-81,444
| -40% | -$1.81M |
|
804
Banco Santander Chile
BSAC
$16.5B
| $2.68M | ﹤0.01% |
169,458
+118,528
| +233% | +$1.77M |
|
805
PagSeguro Digital
PAGS
$2.48B
| $2.68M | ﹤0.01% |
+307,138
| New | +$3.61M |
|
806
Tilly's
TLYS
$127M
| $2.67M | ﹤0.01% |
295,555
+11,864
| +4% | +$104K |
|
|
BNFT
807
DELISTED
Benefitfocus, Inc.
BNFT
| $2.67M | ﹤0.01% |
+255,378
| New | +$2.29M |
|
808
Gran Tierra Energy
GTE
$337M
| $2.63M | ﹤0.01% |
266,131
+42,104
| +19% | +$496K |
|
809
Delek US
DK
$3.92B
| $2.63M | ﹤0.01% |
+97,235
| New | +$2.87M |
|
810
NRG Energy
NRG
$25.2B
| $2.62M | ﹤0.01% |
+82,377
| New | +$3.26M |
|
811
Agilysys
AGYS
$3.01B
| $2.61M | ﹤0.01% |
32,938
+5,482
| +20% | +$349K |
|
812
Park Hotels & Resorts
PK
$2.89B
| $2.6M | ﹤0.01% |
220,778
+29,589
| +15% | +$361K |
|
813
GeoPark
GPRK
$604M
| $2.6M | ﹤0.01% |
168,149
+48,418
| +40% | +$690K |
|
814
Vishay Precision Group
VPG
$894M
| $2.58M | ﹤0.01% |
66,861
+19,541
| +41% | +$712K |
|
815
Illinois Tool Works
ITW
$83.5B
| $2.57M | ﹤0.01% |
+11,653
| New | +$2.48M |
|
816
Universal Technical Institute
UTI
$1.4B
| $2.54M | ﹤0.01% |
378,381
-9,114
| -2% | -$60.2K |
|
817
Verizon
VZ
$196B
| $2.54M | ﹤0.01% |
64,513
-77,167
| -54% | -$2.91M |
|
|
VGR
818
DELISTED
Vector Group Ltd.
VGR
| $2.52M | ﹤0.01% |
+212,045
| New | +$2.24M |
|
819
TFI International
TFII
$11.7B
| $2.49M | ﹤0.01% |
+24,847
| New | +$2.48M |
|
820
Fossil Group
FOSL
$310M
| $2.46M | ﹤0.01% |
571,605
+114,784
| +25% | +$480K |
|
821
Constellation Energy
CEG
$98.6B
| $2.46M | ﹤0.01% |
28,493
+23,580
| +480% | +$2.12M |
|
822
First Busey Corp
BUSE
$2.57B
| $2.45M | ﹤0.01% |
99,211
+28,504
| +40% | +$714K |
|
|
NAPA
823
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $2.45M | ﹤0.01% |
147,590
-32,525
| -18% | -$500K |
|
824
Grupo Aeroportuario Centro Norte
OMAB
$5.23B
| $2.44M | ﹤0.01% |
+39,405
| New | +$2.5M |
|
825
Liberty Latin America Class C
LILAK
$1.66B
| $2.43M | ﹤0.01% |
351,768
-424,181
| -55% | -$2.9M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Arrowstreet Capital held 1,538 positions worth $71.5B, up 5.4% from $67.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $2.85B in Q4 2022, closing 234 positions and reducing 448 holdings. Its most notable exit was AbbVie, an estimated $432M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Gerdau worth $105M.
- Arrowstreet Capital's largest Q4 2022 buy was Gerdau: 23,855,591 shares worth $105M.
- Arrowstreet Capital added most to Visa in Q4 2022, an estimated $268M increase.
- Arrowstreet Capital's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $945M.
- Arrowstreet Capital fully exited AbbVie in Q4 2022, selling an estimated $432M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $71.5B portfolio in Q4 2022.
- Arrowstreet Capital opened 294 new positions and closed 234 in Q4 2022.
- Arrowstreet Capital's portfolio value rose 5.4% quarter-over-quarter to $71.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.